Steward Partners Investment Advisory, LLC - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 86 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2021. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.

Quarter-by-quarter ownership
Steward Partners Investment Advisory, LLC ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2023$23,690
-37.5%
2,3000.0%0.00%
-100.0%
Q2 2023$37,904
+79.9%
2,3000.0%0.00%
Q1 2023$21,068
+27.9%
2,3000.0%0.00%
Q4 2022$16,468
+37.2%
2,3000.0%0.00%
Q3 2022$12,000
+100.0%
2,3000.0%0.00%
Q2 2022$6,000
+20.0%
2,300
+187.5%
0.00%
Q1 2022$5,000
+150.0%
800
+166.7%
0.00%
Q4 2021$2,000
-33.3%
3000.0%0.00%
Q3 2021$3,000
+50.0%
3000.0%0.00%
Q2 2021$2,000
-100.0%
300
-99.0%
0.00%
-100.0%
Q1 2021$264,004,000
+599909.1%
29,204
+345.9%
0.00%
+100.0%
Q4 2020$44,000
+2.3%
6,550
-23.4%
0.00%0.0%
Q3 2020$43,000
-18.9%
8,550
+30.1%
0.00%
-50.0%
Q2 2020$53,000
+10.4%
6,570
+8.6%
0.00%0.0%
Q1 2020$48,000
+50.0%
6,050
+40.7%
0.00%
+100.0%
Q4 2019$32,000
+3100.0%
4,300
+1333.3%
0.00%
Q3 2019$1,0003000.0%0.00%
Q2 2019$0
-100.0%
3000.0%0.00%
Q3 2018$1,000
-50.0%
3000.0%0.00%
Q2 2018$2,0000.0%3000.0%0.00%
Q1 2018$2,0000.0%3000.0%0.00%
Q4 2017$2,0003000.00%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q4 2021
NameSharesValueWeighting ↓
WEALTH EFFECTS LLC 2,409,289$24,815,67612.25%
Knoll Capital Management, LLC 600,000$6,180,0006.42%
Vivo Capital, LLC 4,096,428$42,193,2084.62%
GENDELL JEFFREY L 5,615,350$57,838,1053.29%
Tri Locum Partners LP 983,602$10,131,1013.24%
Samsara BioCapital, LLC 967,527$9,965,5283.05%
MPM BioImpact LLC 664,224$6,841,5071.83%
COWEN AND COMPANY, LLC 2,338,302$24,084,5101.68%
RTW INVESTMENTS, LP 7,136,415$73,505,0751.55%
TANG CAPITAL MANAGEMENT LLC 1,000,000$10,300,0001.45%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders